Impact of cancer therapies on reproductive health
Endocrine Oncology is pleased to announce a themed collection entitled Impact of cancer therapies on reproductive health. New and emerging cancer therapies such as targeted therapies, chemotherapies and immunotherapies are improving the prognosis of many patients with a broad variety of hematological and solid malignancies. As cancer therapies improve, we reflect on their consequential impact on endocrine responses and the function of reproductive organs.
This collection of articles will address the impact of contemporary cancer treatments on reproduction and fertility in both males and females. The review collection focuses on therapies such as chemotherapy, hormone therapy and immunotherapy, which influence ovarian and testis function and fertility in both men and women.
If you are interested in contributing an original research article to this collection, please submit your article proposal to eo@bioscientifica.com.
Collection Editors
Associate Professor Renea Taylor, Associate Editor
Professor of Physiology
Biomedicine Discovery Institute
Monash University, Australia
Dr Swee Du Soon, Guest Editor
Consultant Endocrinologist
SingHealth, Singapore
